Comparable transforming growth factor beta-mediated immune suppression in ex vivo-expanded natural killer cells from cord blood and peripheral blood: implications for adoptive immunotherapy.
Cytotherapy
; 24(8): 802-817, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35589475
Full text:
1
Database:
MEDLINE
Main subject:
Immunotherapy, Adoptive
/
Transforming Growth Factor beta
/
Graft vs Host Disease
Limits:
Humans
Language:
En
Journal:
Cytotherapy
Journal subject:
TERAPEUTICA
Year:
2022
Type:
Article
Affiliation country:
United States